Europe Biosimilars Market Size, by Country (2024–2032)

Free

in USD Million

Italy Leads to Drive Europe Biosimilars Market (2024-2032)

Published by MMR Statistics Reserch Team, November 2025

Policy adjustments reshaped regional dynamics in 2024, when France was valued at USD 1,569.97 million, the United Kingdom reached USD 1,383.78 million, and Germany posted USD 2,020.58 million. The 2025 landscape is estimated to progress, with Italy at USD 2,594.18 million. From 2026 to 2032, values are projected to climb, with Italy dominating at USD 6,769.25 million as the Europe Biosimilars Market expands, driven by Italy’s concentrated therapeutic portfolios and favorable reimbursement policies.

OTHER STATISTICS ON TOPIC

Biosimilars

More statistics on Biosimilars

Download

Information

Unit

in USD Million

Region

Europe

Time Period

2024-2032

Source Name

Maximize Market Research Pvt. Ltd

Source Link

http://www.maximizemarketresearch.com

Publisher Name

Maximize Market Research Pvt. Ltd

Publisher Link

http://www.maximizemarketresearch.com

Related reports

Market Research Reports on Biosimilars

Explore published research tied to this statistic's topic. Open the featured edition or jump into another region without leaving the page.

Open featured report

Subscriptions

Stay ahead of Biosimilars with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Start for Free

Professional

Unlock premium coverage across this topic with analyst support.

Select Plan

Contact our team

Need a bespoke deep-dive on Biosimilars?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.

Talk with an analyst